BSE has issued a notice (No. 20260421-37) informing trading members of the new ISIN number assigned to ANLON HEALTHCARE LTD (Scrip Code: 544497) following the sub-division of its equity shares from Rs.10/- to Rs.2/- per share. This is a continuation of Exchange Notice No. 20260415-36 dated April 15, 2026.

Key Points

• New ISIN assigned to ANLON HEALTHCARE LTD: INE0Y8W01025
• The share sub-division reduces face value from Rs.10/- to Rs.2/- per share
• The new ISIN is effective from the Ex-Date: April 24, 2026 (DR-617/2026-2027)
• This notice is a follow-up to Exchange Notice No. 20260415-36 dated April 15, 2026

Regulatory Changes

The sub-division of equity shares necessitates the issuance of a new ISIN. The old ISIN is replaced by INE0Y8W01025 for all trades involving the sub-divided equity shares of ANLON HEALTHCARE LTD.

Compliance Requirements

• Trading members must update their systems to reflect the new ISIN (INE0Y8W01025) for ANLON HEALTHCARE LTD (Scrip Code: 544497)
• All trades on and from the ex-date must reference the new ISIN
• Depository participants and custodians should ensure proper migration of holdings to the new ISIN

Important Dates

• Notice Date: April 21, 2026
• Ex-Date (effective date for new ISIN): April 24, 2026
• Reference DR Number: DR-617/2026-2027
• Prior Notice: Exchange Notice No. 20260415-36 dated April 15, 2026

Impact Assessment

The new ISIN assignment is an operational necessity following the share sub-division of ANLON HEALTHCARE LTD. Trading members and investors holding the scrip must ensure their records are updated before the ex-date of April 24, 2026. Failure to update systems to reflect the new ISIN could result in settlement issues. The sub-division itself (from Rs.10/- to Rs.2/-) increases the number of shares outstanding proportionally, potentially improving liquidity for the stock.